These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Studies on the Structure and Properties of Membrane Phospholipase A Bakholdina SI; Stenkova AM; Bystritskaya EP; Sidorin EV; Kim NY; Menchinskaya ES; Gorpenchenko TY; Aminin DL; Shved NA; Solov'eva TF Molecules; 2021 Jun; 26(13):. PubMed ID: 34203222 [TBL] [Abstract][Full Text] [Related]
6. Small surfactant-like peptides can drive soluble proteins into active aggregates. Zhou B; Xing L; Wu W; Zhang XE; Lin Z Microb Cell Fact; 2012 Jan; 11():10. PubMed ID: 22251949 [TBL] [Abstract][Full Text] [Related]
7. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Díez-Gil C; Krabbenborg S; García-Fruitós E; Vazquez E; Rodríguez-Carmona E; Ratera I; Ventosa N; Seras-Franzoso J; Cano-Garrido O; Ferrer-Miralles N; Villaverde A; Veciana J Biomaterials; 2010 Aug; 31(22):5805-12. PubMed ID: 20452667 [TBL] [Abstract][Full Text] [Related]
8. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4 Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293 [TBL] [Abstract][Full Text] [Related]
9. Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs. Céspedes MV; Fernández Y; Unzueta U; Mendoza R; Seras-Franzoso J; Sánchez-Chardi A; Álamo P; Toledo-Rubio V; Ferrer-Miralles N; Vázquez E; Schwartz S; Abasolo I; Corchero JL; Mangues R; Villaverde A Sci Rep; 2016 Oct; 6():35765. PubMed ID: 27775083 [TBL] [Abstract][Full Text] [Related]
10. Purification of inclusion body-forming peptides and proteins in soluble form by fusion to Escherichia coli thermostable proteins. Thapa A; Shahnawaz M; Karki P; Raj Dahal G; Sharoar MG; Yub Shin S; Sup Lee J; Cho B; Park IS Biotechniques; 2008 May; 44(6):787-96. PubMed ID: 18476832 [TBL] [Abstract][Full Text] [Related]
11. Amyloid-like properties of bacterial inclusion bodies. Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261 [TBL] [Abstract][Full Text] [Related]
12. Active inclusion body formation using Paenibacillus polymyxa PoxB as a fusion partner in Escherichia coli. Park SY; Park SH; Choi SK Anal Biochem; 2012 Jul; 426(1):63-5. PubMed ID: 22490467 [TBL] [Abstract][Full Text] [Related]
13. Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids. Wasmer C; Benkemoun L; Sabaté R; Steinmetz MO; Coulary-Salin B; Wang L; Riek R; Saupe SJ; Meier BH Angew Chem Int Ed Engl; 2009; 48(26):4858-60. PubMed ID: 19472238 [TBL] [Abstract][Full Text] [Related]
14. Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics. Rothan HA; Ambikabothy J; Abdulrahman AY; Bahrani H; Golpich M; Amini E; A Rahman N; Teoh TC; Mohamed Z; Yusof R PLoS One; 2015; 10(9):e0139248. PubMed ID: 26418816 [TBL] [Abstract][Full Text] [Related]
16. Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications. Roca-Pinilla R; Fortuna S; Natalello A; Sánchez-Chardi A; Ami D; Arís A; Garcia-Fruitós E Microb Cell Fact; 2020 Sep; 19(1):175. PubMed ID: 32887587 [TBL] [Abstract][Full Text] [Related]
17. Bacterial inclusion bodies: an emerging platform for drug delivery and cell therapy. Villaverde A Nanomedicine (Lond); 2012 Sep; 7(9):1277-9. PubMed ID: 22994952 [No Abstract] [Full Text] [Related]